Transmission and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak

  • Yousef Sawikr pharmacology lecturer at University of Ajdabiya

Abstract

The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unmatched challenges to the healthcare systems in almost every country around the world. Currently, there are no established effective vaccines or therapeutic agents against the virus. Present clinical management includes infection prevention and control process and supportive care including supplemental oxygen and mechanical ventilator support. It is proposed this is likely the zoonotic beginning of COVID-19. Individual to-individual transmission of COVID-19 contamination prompted the separation of patients that were accordingly managed an assortment of medicines.


Keywords: COVID-19, SARS-CoV-2, supplemental oxygen, ventilator support

Keywords: COVID-19, SARS-CoV-2, supplemental oxygen, ventilator support

Downloads

Download data is not yet available.

References

1. Su S, Wong G, Shi W, Liu J, Lai A, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Elsevier [Internet]. [cited 2020 Sep 4]; Available from: https://www.sciencedirect.com/science/article/pii/S0966842X16000718
2. Wu R, Wang L, Kuo H, Shannar A, … RP-CP, 2020 undefined. An update on current therapeutic drugs treating COVID-19. Springer [Internet]. [cited 2020 Aug 25]; Available from: https://link.springer.com/content/pdf/10.1007/s40495-020-00216-7.pdf
3. Schoeman D, Fielding BC. Coronavirus envelope protein: Current knowledge. Vol. 16, Virology Journal. BioMed Central Ltd.; 2019.
4. Weiss SR, Navas-Martin S. Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus. Microbiol Mol Biol Rev [Internet]. 2005 [cited 2020 Sep 5]; 69(4):635–64. Available from: http://mmbr.asm.org/
5. An update on current therapeutic drugs treating COVID-19. Springer [Internet]. [cited 2020 Sep 5]; Available from: https://link.springer.com/content/pdf/10.1007/s40495-020-00216-7.pdf
6. Eissenberg T, Kanj SS, Shihadeh AL. Treat COVID-19 as Though It Is Airborne: It May Be. AANA journal. NLM (Medline); 2020; 88:29–30.
7. Morawska L, International JC-E, 2020 undefined. Airborne transmission of SARS-CoV-2: The world should face the reality. Elsevier [Internet]. [cited 2020 Sep 5]; Available from: https://www.sciencedirect.com/science/article/pii/S016041202031254X
8. Liu J, Liao X, Qian S, Yuan J, Wang F, Liu Y, et al. Community Transmission of SARS-CoV-2. 2020 [cited 2020 Sep 6]; Available from: https://doi.org/10.1016/S0140-6736
9. Jama LB-, 2020 undefined. Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19. jamanetwork.com [Internet]. [cited 2020 Sep 6]; Available from: https://jamanetwork.com/journals/jama/article-abstract/2763852
10. Ong S, Tan Y, Chia P, Lee T, Jama ON-, 2020 undefined. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic. jamanetwork.com [Internet]. [cited 2020 Sep 6]; Available from: https://jamanetwork.com/journals/jama/article-abstract/2762692
11. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020 Feb [cited 2020 Sep 6];395(10223):497–506. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673620301835
12. Sanders J, Monogue M, Jodlowski T, Jama JC-, 2020 undefined. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. jamanetwork.com [Internet]. [cited 2020 Aug 25]; Available from: https://jamanetwork.com/journals/jama/article-abstract/2764727
13. Rothan H, autoimmunity SB-J of, 2020 undefined. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Elsevier [Internet]. [cited 2020 Sep 6]; Available from: https://www.sciencedirect.com/science/article/pii/S0896841120300469
14. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Elsevier [Internet]. [cited 2020 Aug 24]; Available from: https://www.sciencedirect.com/science/article/pii/S0140673620301835
15. Ronco C, Nephrology TR-NR, 2020 undefined. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. nature.com [Internet]. [cited 2020 Aug 24]; Available from: https://www.nature.com/articles/s41581-020-0284-7
16. Bai Y, Yao L, Wei T, Tian F, Jin D, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. jamanetwork.com [Internet]. [cited 2020 Aug 24]; Available from: https://jamanetwork.com/journals/jama/article-abstract/2762028
17. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, international LD-K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Elsevier [Internet]. [cited 2020 Aug 24]; Available from: https://www.sciencedirect.com/science/article/pii/S0085253820302556
18. Kumar A, Zarychanski R, Pinto R, Cook D, Jama JM-, 2009 undefined. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. jamanetwork.com [Internet]. [cited 2020 Aug 24]; Available from: https://jamanetwork.com/journals/jama/article-abstract/184799
Statistics
39 Views | 27 Downloads
How to Cite
1.
Sawikr Y. Transmission and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak. JDDT [Internet]. 17Nov.2020 [cited 26Nov.2020];10(6):239-41. Available from: http://jddtonline.info/index.php/jddt/article/view/4577